emend capsule 80 mg
msd pharma (singapore) pte. ltd. - aprepitant - capsule - 80 mg - aprepitant 80 mg
emend tri-pack capsule
msd pharma (singapore) pte. ltd. - aprepitant (in 125 mg capsule); aprepitant (in 80 mg capsule) - capsule - 125 mg - aprepitant (in 125 mg capsule) 125 mg; aprepitant (in 80 mg capsule) 80 mg
emend® i.v. powder for solution for infusion 150mg
msd pharma (singapore) pte. ltd. - fosaprepitant dimeglumine 245.3mg eqv fosaprepitant - injection, powder, lyophilized, for solution - 150.0 mg - fosaprepitant dimeglumine 245.3mg eqv fosaprepitant 150.0 mg
ivemend
merck sharp & dohme b.v. - fosaprepitant - vomiting; cancer - antiemetics and antinauseants, - prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and paediatric patients aged 6 months and older.ivemend 150 mg is given as part of a combination therapy.
emend capsule
merck canada inc - aprepitant - capsule - 80mg - aprepitant 80mg - neurokinin-1 receptor antagonists
emend capsule
merck canada inc - aprepitant - capsule - 125mg - aprepitant 125mg - neurokinin-1 receptor antagonists
emend tri-pack kit
merck canada inc - aprepitant; aprepitant - kit - 125mg; 80mg - aprepitant 125mg; aprepitant 80mg - neurokinin-1 receptor antagonists
aprepitant 40mg/5ml oral suspension
special order - aprepitant - oral suspension - 8mg/1ml
aprepitant 25mg/5ml oral suspension
special order - aprepitant - oral suspension - 5mg/1ml
aprepitant 30mg/5ml oral suspension
special order - aprepitant - oral suspension - 6mg/1ml